Ozempic is FDA-approved for two indications: To improve blood sugar control in adults with type 2 diabetes To reduce the risk of major cardiovascular events, such as heart attack or stroke, in adults with type 2 diabetes and heart disease Wegovy is also FDA-approved for two indications: To reduce body weight and maintain weight loss in adults and children ages 12 and up with obesity, as well as in adults with overweight and at least one weight-related health condition To reduce the risk of major cardiovascular events, such as heart attack or stroke, in adults with heart disease and either obesity or overweight Rybelsus is FDA-approved to treat type 2 diabetes by improving blood sugar control
Patients with straightforward medical histories may find compounded options adequate, while those with complex conditions might prefer the extensive safety data available for brand medications
Data availability The data supporting the findings of this study are available within the paper and its Supplementary Information
Sustained appetite control also stabilizes blood sugar levels and reduces postprandial (after-meal) glucose spikes, benefits that extend to non-diabetic patients managing metabolic health
S., Poursharif, B., Korst, L
